Results 131 to 140 of about 53,085 (229)

Extracorporeal Free-Light-Chain Removal in Myeloma Cast Nephropathy: Plasma Exchange and Hemodialysis Strategies in the Era of Effective Antimyeloma Therapy. [PDF]

J Clin Med
Gembillo G, Soraci L, Lo Cicero L, Terzo C, Casuscelli C, Cuzzola F, Sudano F, Ricca MF, Scapellato M, Messina R, La Spada A, Sharma A, Santoro D.   +12 more
europepmc   +1 more source

Effect of the Proteasome Inhibitor, Bortezomib, on Histone Modifications in Human Leukemic Cell Lines. [PDF]

Int J Mol Sci
Sattarifard H, Oyeyode M, Prajapati D, Duaqui A, Kaur G, Muker I, Luo W, Lakowski TM, Davie JR.   +8 more
europepmc   +1 more source

Clinical outcome and exploratory analysis of endoplasmic reticulum stress marker in feline plasma cell-derived neoplasms treated with bortezomib: a retrospective pilot study

Hiroyuki Tani, Ryo Miyamoto, Hirotaka Kondo, Nene Morohashi, Y. Sakamoto, Haruhiko MARUYAMA, Tomohiro Nakayama   +6 more
openalex   +1 more source

Cardiovascular disease and amyloidosis in phase III multiple myeloma trials: a systematic review of eligibility, screening and event reporting. [PDF]

Open Heart
Henriques Peck O, McCoubrey A, Snowden JA, Wechalekar A, Travers J, Lees JS, Petrie MC, Lang NN.   +7 more
europepmc   +1 more source

SLC45A4-mediated putrescine uptake functionally modulates HOXA1 and promotes bortezomib resistance in multiple myeloma

Jun Xu, Peng Shu, Liang Zhang, Huihui Li, Zhouyi Xu, Bo Meng, Julei Ma, Wei Wang, Wenjuan Wang, Xiaobing Wu, Zhe Wang   +10 more
openalex   +1 more source

DARATUMUMAB PLUS BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL ANALYSIS OF TRANSPLANT-INELIGIBLE PATIENTS IN THE PHASE 3 CEPHEUS STUDY [PDF]

Saad Z USMANI, Thierry T.F. Facon, Vania Hungria, Nizar Jacques Bahlis, Christopher Paul Venner, Marc BRAUNSTEIN, Luděk Pour, Josep Marti, Supratik Basu, Yael C COHEN, Kenshi Suzuki, Cyrille Hulin, Sebastian Grosicki, Meral Beksaç, Angelo MAIOLINO, Jaclyn Stanziola, Lorena Lopez-Masi, Matteo Loi, Melissa Rowe, Sonja ZWEEGMAN   +19 more
openalex   +1 more source

Hepatotoxicity Profile of Bortezomib-Containing Regimens for First-Line Multiple Myeloma Treatment. [PDF]

Pharmaceuticals (Basel)
Lucijanic M, Orec J, Soric E, Sabljic A, Jonjic Z, Pirsic M, Jaksic O.   +6 more
europepmc   +1 more source

Figure S4 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance

Chengxi Li, Yu‐Hsuan A. Chang, Minori Maki, Ikuko Omori, Naru Sato, Susumu Goyama, Toshio Kitamura, Yutaka Enomoto   +7 more
openalex   +1 more source

A rat model of mild, reversible bortezomib-induced peripheral neuropathy: behavioral resolution despite persistent glial activation [PDF]

Mona Hashemian, Elisabete Bóf Ramos, Mariam Sobhy Atalla, Nadine Cebulla, Jonas Hühn, Oliver Scherf‐Clavel, Grit Hein, K. Martin Kortüm, Heike Lydia Rittner, Claudia Sommer   +9 more
openalex   +1 more source

Thermodynamic Preference Between Deprotonation Pathways in Boronic Acid-Based Proteasome Inhibitors: Insights from a DFT Study. [PDF]

Pharmaceuticals (Basel)
Toshev N, Dimitrov I, Muradyan O, Delchev V, Dudev T.   +4 more
europepmc   +1 more source